Prevalence of arterial hypertension and lipid profile in HIV patients;Prevalencia de hipertensión arterial y perfil lipídico en pacientes con infección por el virus de la inmunodeficiencia humana

Medicina Clinica

Volumn 131, Issue 18, 2008, Pages 681-684

  Coloma Conde, Ana G ^a   Álvarez Albarrán, Maite ^a   Roca Cusachs Coll, Alejandro ^a   Domingo Pedrol, Pere ^a   Puig Campmany, Mireia ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Blood pressure; HIV; Lipid profile; Lipodystrophy

Indexed keywords

ADULT; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; DISEASE DURATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; TREATMENT DURATION;

ADULT; CHOLESTEROL; CHOLESTEROL, HDL; FEMALE; HIV INFECTIONS; HUMANS; HYPERTENSION; MALE; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 63149147962     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1157/13129111     Document Type: Article

References (30)

1. Gazzaruso C., Bruno R., Garzaniti A., Giordanetti S., Fratino P., and Sacchi P. Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome. J Hypertens 21 (2003) 1377-1382
2. Bergensen B.M., Sandvik L., Dunlop O., Birkeland K., and Bruun J.N. Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: results from a Norwegian study of 721 patients. Eur J Clin Microbiol Infect Dis 22 (2003) 731-736
3. Jerico C., Knobel H., Montero M., Sorli M.L., Guelar A., Gimeno J.L., et al. Hypertension in HIV-infected patients: prevalence and related factors. Am J Hypertens 18 (2005) 396-1401
4. Friis-Moller N., Weber R., Reiss P., Thiebaut R., Kirk O., D'Arminio Monforte A., et al., DAD study group. Cardiovascular disease risk factors in HIV patients - association with antiretroviral therapy. Results from the DAD study. AIDS 17 (2003) 1179-1193
5. Seaberg E.C., Muñoz A., Lu M., Detels R., Margolick J.B., Riddler S.A., et al., for the Multicenter AIDS Cohort Study. Association between highly active antiretroviral therapy and hypertension in a large cohort of men followed from 1984 to 2003. AIDS 19 (2005) 953-960
6. Aoun S., and Ramos E. Hypertension in HIV- infected pacient. Curr Hypertens Rep 5 (2000) 478-481
7. Crane H.M., Van Rompaey S.E., and Kitathata M.M. Antiretroviral medications associated with elevated blood pressure among patients receiving hughly active antiretroviral therapy. AIDS 20 (2006) 1019-1026
8. CDC. 1993 revised classification system for HIV infection and surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 41 (1992) 1-17
9. Garg A. Lipodystrophies. Am J Med 108 (2000) 143-152
10. Third Report of the National Cholesterol Education Program (NCEP). Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation 106 (2002) 3143-3421
11. Wilson P.W., D'Angostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 (1998) 1837-1847
12. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1105-87.
13. Sociedad Española de Hipertensión-Liga de Lucha contra la Hipertensión Arterial (SEH-LEA). Guía española de hipertensión arterial 2005. Hipertensión. 2005;22 Supl 2:3-8.
14. García-Lázaro M., Rivero A., Camacho A., Pérez-Camacho I., Natera C., Castón J., et al. Variabilidad en la valoración del riesgo coronario en pacientes infectados por el virus de la inmunodeficiencia humana. Med Clin (Barc) 129 (2007) 521-524
15. Wali R.K., Drachenberg C.I., Papadimitriou J.C., Keay S., and Ramos E. HIV- associated a nefropathy and response to highly- active antiretroviral therapy. Lancet 352 (1998) 783-784
16. Hanabusa H., Tagami H., and Hataya H. Renal atrophy associated with long-term treatament with indinavir. N Engl J Med 340 (1999) 392-393
17. D'Arminio A., Sabin C.A., Phillips A.N., Reiss P., Weber R., Kirk O., et al., Writing Committee of the DAD Study Group. Cardio- and cerebrovascular events in HIV-infected persons. AIDS 18 (2004) 1811-1817
18. Currier J.S., Kendall M.A., ZacKin R., Henry W.R., Alston-Smith B., Torriani F.J., et al. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS 19 (2005) 927-933
19. Frield A.C., Attenhofer C.H., Schalcher C., Amann F.W., Flepp M., Jenni R., et al. Acceleration of cofirmed cornary artery disease among HIV-infected patients on potent antiretroviral therapy. AIDS 14 (2000) 2790-2792
20. Jerico C., Knobel H., Carmona A., Sorli M.L., López-Colomes J.L., and Pedro-Botet J. Enfermedad cardiovascular sintomática en pacientes infectados por el virus de la inmunodeficiencia humana que reciben tratamiento antirretroviral de gran actividad. Med Clin (Barc) 122 (2004) 298-300
21. Mehta N., and Reilly M. Atherosclerotic cardiovascular disease risk in the HAART-treated HIV-1 population. HIV Clin Trials 6 (2005) 5-24
22. Bergersen B.M., Sandvik L., Bruun J.N., and Tonstad S. Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects. Eur J Clin Microbiol Infect Dis 23 (2004) 625-630
23. Grinspoon S., and Carr A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. N Engl J Med 352 (2005) 48-62
24. Steinhart C.R., and Emons M.F. Risks of cardiovascular disease in patients receiving antiretroviral therapy for HIV infection: implications for treatment. AIDS Read 14 (2004) 86-90
25. Neumann T., Woiwoid T., Neumann A., Miller M., Ross B., Volbracht L., et al. Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients: part I. Differences due to the acquisition of HIV-infection. Eur J Med Res 8 (2003) 229-235
26. Neumann T., Woiwod T., Neumann A., Ross B., Von Birgelen C., Volbracht L., et al. Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part II: gender differences. Eur J Med Res 9 (2004) 55-60
27. Neumann T., Woiwod T., Neumann A., Miller M., Von Birgelen C., Volbracht L., et al. Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients - Part III: age differences. Eur J Med Res 9 (2004) 267-272
28. Fred R., Sattler F., Qian D., Louie D., Johnson D., Briggs W., et al. Elevated blood pressure in subjects with lipodystrophy. AIDS 15 (2001) 2001-2010
29. Hadigan C., Meigs J.B., Wilson P.W., D'Agostino R.B., Davis B., Basgoz N., et al. Prediction of coronary heart disease risk in HIV-infected patients with fat redistribution. Clin Infect Dis 36 (2003) 909-916
30. Lichtenstein K.A., Ward D.J., Moorman A.C., Delaney K.M., Young B., Palella Jr. F.J., et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 15 (2001) 1389-1398